Rockefeller Capital Management L.P.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1739439
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,445,391
-$8,590,300 QoQ
Shares Held
21,563
-24.4% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#258
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rockefeller Capital Management L.P. holds $307,135,875 across 241 Biotechnology names. REGN ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
149,476 | $74,249,211 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
167,409 | $40,340,545 | |
| 3 | ACAD |
Acadia Pharmaceuticals Inc
|
1,015,420 | $25,690,124 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
433,376 | $24,797,774 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
302,393 | $24,666,195 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
29,015 | $15,579,603 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
21,563 | $13,445,391 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
123,388 | $10,728,585 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,445,391 | 21,563 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $22,035,691 | 28,520 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $20,881,397 | 27,053 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $14,530,180 | 25,842 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $15,550,500 | 29,620 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $42,879,019 | 67,608 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $67,488,992 | 94,744 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $103,025,723 | 98,004 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $104,157,071 | 99,100 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $100,773,663 | 104,701 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $92,757,083 | 105,611 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $85,596,890 | 104,011 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $56,543,348 | 78,692 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $62,002,394 | 75,459 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $54,462,393 | 75,486 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $55,736,470 | 80,910 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $48,324,285 | 81,749 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $64,011,588 | 91,652 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $54,411,762 | 86,160 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $52,852,788 | 87,334 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $105,982,964 | 189,750 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $60,208,008 | 127,252 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $52,475,890 | 108,621 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $58,541,791 | 104,580 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $82,196,445 | 131,799 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $65,679,398 | 134,509 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||